Literature DB >> 16138907

Nuclear translocation of cell-surface receptors: lessons from fibroblast growth factor.

David M Bryant1, Jennifer L Stow.   

Abstract

The nuclear localization of a number of growth factors, cytokine ligands and their receptors has been reported in various cell lines and tissues. These include members of the fibroblast growth factor (FGF), epidermal growth factor and growth hormone families. Accordingly, a number of nuclear functions have begun to emerge for these protein families. The demonstration of functional interactions of these proteins with the nuclear import machinery has further supported their functions as nuclear signal transducers. Here, we review the membrane- trafficking machinery and pathways demonstrated to regulate this cell surface to nucleus-trafficking event and highlight the many remaining unanswered questions. We focus on the FGF family, which is providing many of the clues as to the process of this unusual phenomenon.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16138907     DOI: 10.1111/j.1600-0854.2005.00332.x

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  59 in total

Review 1.  Nuclear trafficking of the epidermal growth factor receptor family membrane proteins.

Authors:  Y-N Wang; H Yamaguchi; J-M Hsu; M-C Hung
Journal:  Oncogene       Date:  2010-05-17       Impact factor: 9.867

Review 2.  Proteomic identification of multitasking proteins in unexpected locations complicates drug targeting.

Authors:  Georgina S Butler; Christopher M Overall
Journal:  Nat Rev Drug Discov       Date:  2009-12       Impact factor: 84.694

3.  COPI-mediated retrograde trafficking from the Golgi to the ER regulates EGFR nuclear transport.

Authors:  Ying-Nai Wang; Hongmei Wang; Hirohito Yamaguchi; Hong-Jen Lee; Heng-Huan Lee; Mien-Chie Hung
Journal:  Biochem Biophys Res Commun       Date:  2010-07-30       Impact factor: 3.575

4.  Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER+ Breast Cancer.

Authors:  Luigi Formisano; Kimberly M Stauffer; Christian D Young; Neil E Bhola; Angel L Guerrero-Zotano; Valerie M Jansen; Mónica M Estrada; Katherine E Hutchinson; Jennifer M Giltnane; Luis J Schwarz; Yao Lu; Justin M Balko; Olivier Deas; Stefano Cairo; Jean-Gabriel Judde; Ingrid A Mayer; Melinda Sanders; Teresa C Dugger; Roberto Bianco; Thomas Stricker; Carlos L Arteaga
Journal:  Clin Cancer Res       Date:  2017-07-27       Impact factor: 12.531

5.  Common developmental genome deprogramming in schizophrenia - Role of Integrative Nuclear FGFR1 Signaling (INFS).

Authors:  S T Narla; Y-W Lee; C A Benson; P Sarder; K J Brennand; E K Stachowiak; M K Stachowiak
Journal:  Schizophr Res       Date:  2017-01-13       Impact factor: 4.939

Review 6.  Steroid-like signalling by interferons: making sense of specific gene activation by cytokines.

Authors:  Howard M Johnson; Ezra N Noon-Song; Kaisa Kemppainen; Chulbul M Ahmed
Journal:  Biochem J       Date:  2012-04-15       Impact factor: 3.857

Review 7.  Trafficking of receptor tyrosine kinases to the nucleus.

Authors:  Graham Carpenter; Hong-Jun Liao
Journal:  Exp Cell Res       Date:  2008-10-11       Impact factor: 3.905

8.  Dendrimer-based tumor cell targeting of fibroblast growth factor-1.

Authors:  Thommey P Thomas; Rameshwer Shukla; Alina Kotlyar; Jola Kukowska-Latallo; James R Baker
Journal:  Bioorg Med Chem Lett       Date:  2009-12-03       Impact factor: 2.823

9.  Induction of stem cell gene expression in adult human fibroblasts without transgenes.

Authors:  Raymond L Page; Sakthikumar Ambady; William F Holmes; Lucy Vilner; Denis Kole; Olga Kashpur; Victoria Huntress; Ina Vojtic; Holly Whitton; Tanja Dominko
Journal:  Cloning Stem Cells       Date:  2009-09

Review 10.  Fibroblast growth factor signalling: from development to cancer.

Authors:  Nicholas Turner; Richard Grose
Journal:  Nat Rev Cancer       Date:  2010-02       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.